Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-26

Clinical Trial Update: A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary Retinopathy

View source ↗

Summary

This clinical trial update reports on a completed Janssen-sponsored study of pentosan polysulfate sodium (Elmiron). The study investigates the development of pi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elmiron (pentosan polysulfate sodium)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Pigmentary Maculopathy, Pigmentary Retinopathy | Status: COMPLETED